114 related articles for article (PubMed ID: 38664583)
1. Role of ferroptosis in hepatocellular carcinoma.
Nie J; Lin B; Zhou M; Wu L; Zheng T
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2329-2337. PubMed ID: 30167889
[TBL] [Abstract][Full Text] [Related]
2. The emerging role of fatty acid binding protein 5 (FABP5) in cancers.
George Warren W; Osborn M; Yates A; Wright K; O'Sullivan SE
Drug Discov Today; 2023 Jul; 28(7):103628. PubMed ID: 37230284
[TBL] [Abstract][Full Text] [Related]
3. Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring.
Sun J; Esplugues E; Bort A; Cardelo MP; Ruz-Maldonado I; Fernández-Tussy P; Wong C; Wang H; Ojima I; Kaczocha M; Perry R; Suárez Y; Fernández-Hernando C
Nat Metab; 2024 Apr; 6(4):741-763. PubMed ID: 38664583
[TBL] [Abstract][Full Text] [Related]
4. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition.
Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A
Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947
[TBL] [Abstract][Full Text] [Related]
5. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing.
Hao X; Zheng Z; Liu H; Zhang Y; Kang J; Kong X; Rong D; Sun G; Sun G; Liu L; Yu H; Tang W; Wang X
Redox Biol; 2022 Oct; 56():102463. PubMed ID: 36108528
[TBL] [Abstract][Full Text] [Related]
7. Altered fatty acid-binding protein 4 (FABP4) expression and function in human and animal models of hepatocellular carcinoma.
Thompson KJ; Austin RG; Nazari SS; Gersin KS; Iannitti DA; McKillop IH
Liver Int; 2018 Jun; 38(6):1074-1083. PubMed ID: 29171144
[TBL] [Abstract][Full Text] [Related]
8. Lipid-related FABP5 activation of tumor-associated monocytes fosters immune privilege via PD-L1 expression on Treg cells in hepatocellular carcinoma.
Liu J; Sun B; Guo K; Yang Z; Zhao Y; Gao M; Yin Z; Jiang K; Dong C; Gao Z; Ye M; Liu J; Wang L
Cancer Gene Ther; 2022 Dec; 29(12):1951-1960. PubMed ID: 35902729
[TBL] [Abstract][Full Text] [Related]
9. TREM2
Tan J; Fan W; Liu T; Zhu B; Liu Y; Wang S; Wu J; Liu J; Zou F; Wei J; Liu L; Zhang X; Zhuang J; Wang Y; Lin H; Huang X; Chen S; Kuang M; Li J
J Hepatol; 2023 Jul; 79(1):126-140. PubMed ID: 36889359
[TBL] [Abstract][Full Text] [Related]
10. FABP5 deletion in nociceptors augments endocannabinoid signaling and suppresses TRPV1 sensitization and inflammatory pain.
Bogdan DM; Studholme K; DiBua A; Gordon C; Kanjiya MP; Yu M; Puopolo M; Kaczocha M
Sci Rep; 2022 Jun; 12(1):9241. PubMed ID: 35655086
[TBL] [Abstract][Full Text] [Related]
11. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma.
Hanif H; Ali MJ; Susheela AT; Khan IW; Luna-Cuadros MA; Khan MM; Lau DT
World J Gastroenterol; 2022 Jan; 28(2):216-229. PubMed ID: 35110946
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress-induced FABP5 S-glutathionylation protects against acute lung injury by suppressing inflammation in macrophages.
Guo Y; Liu Y; Zhao S; Xu W; Li Y; Zhao P; Wang D; Cheng H; Ke Y; Zhang X
Nat Commun; 2021 Dec; 12(1):7094. PubMed ID: 34876574
[TBL] [Abstract][Full Text] [Related]
13. Targeting TREM2 on tumor-associated macrophages enhances immunotherapy.
Binnewies M; Pollack JL; Rudolph J; Dash S; Abushawish M; Lee T; Jahchan NS; Canaday P; Lu E; Norng M; Mankikar S; Liu VM; Du X; Chen A; Mehta R; Palmer R; Juric V; Liang L; Baker KP; Reyno L; Krummel MF; Streuli M; Sriram V
Cell Rep; 2021 Oct; 37(3):109844. PubMed ID: 34686340
[TBL] [Abstract][Full Text] [Related]
14. Lineage tracing and single-cell analysis reveal proliferative Prom1+ tumour-propagating cells and their dynamic cellular transition during liver cancer progression.
Zhou L; Yu KH; Wong TL; Zhang Z; Chan CH; Loong JH; Che N; Yu HJ; Tan KV; Tong M; Ngan ES; Ho JW; Ma S
Gut; 2022 Aug; 71(8):1656-1668. PubMed ID: 34588223
[TBL] [Abstract][Full Text] [Related]
15. CCAT1/FABP5 promotes tumour progression through mediating fatty acid metabolism and stabilizing PI3K/AKT/mTOR signalling in lung adenocarcinoma.
Chen J; Alduais Y; Zhang K; Zhu X; Chen B
J Cell Mol Med; 2021 Oct; 25(19):9199-9213. PubMed ID: 34431227
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
